Online
|
|
buy
Posted by :
LEO THE LION
have you seen jubilant ..its at 300+ now a days. i gave a buy call at 170`s
now what do you say?...
Jubilant Organosys forms JV with.........
Posted by : pms.swastika
Jubilant Organosys forms JV with.........
Jubilant Organosys, University of Alabama at Birmingham (UAB), and Southern Research enter into Drug Discovery JV.
Regards
Swastika PMS...
KAISI RAHI
Posted by : 300567TODAY IT IS 315. TARGET WILL BE ACHIEVED SOON...
TARGET RS 365 NOW
Posted by : Guestjust want to know what are the next targets for this,whether it will touch 400 in this week...
DEKHA KYA KAHA THA
Posted by : 300567TARGET RS 365 IN NOT FAR AWAY....
Jubilant Organosys
Posted by : rupesh711in
Jubilant Organosys HAS MADE:-
Nov 11, 2009 Bottom Triangle Long-Term Bullish AT-273.55
Nov 11, 2009 Continuation Diamond (Bullish) Intermediate-Term Bullish AT-273.55
Nov 11, 2009 Price Crosses Moving Average (50-day) Intermediate-Term Bullish AT-273.55
Nov 11, 2009 Symmetrical Continuation Triangle (Bullish) Intermediate-Term Bullish AT-273.55
TRGTS LONG TERM - 384 - 415
...
TARGET RS 365 NOW
Posted by :
cmetThough intraday it touched 320 it is back again down to 290.Will it touch 365 in short term??...
TARGET RS 365 NOW
Posted by : 300567I AM REVISING MY TARGET. FIRST TARGET OF RS 320 IS ACHIEVED...
Sale of Divisions
Posted by : cmet
The companys plans to sell their Application Polymers Division and the Consumer Products Division and to concentrate on their pharma business has gone down well with investors.
Further the tie up with Duke University for a Global Research and Drug Development Partnership will enhance their R&D.
The share is now being rerated and it can be seen in the sharp rise yesterday....
Research-Biomaker study
Posted by : rvk41
Jubilant Organosys has announced a strategic research and development tie up with U.S.-based Duke University and Naresh Trehan-promoted super specialty healthcare facility Medanta. The company has also decided to set up three new hospitals near Kolkata with an investment of Rs. 185 crore in the next one year.
Announcing this at a press conference here, company Chairman and Managing Director Shyam S. Bhartia said Jubilant and the Duke University would jointly develop molecules from the U.S.-based institute’s intellectual property right portfolio.
Jubilant would conduct phase I and phase II clinical trials on the molecules provided by Duke at Medanta, which has earmarked 60 bed dedicated research facility Medanta Duke Research Institute (MDRI) inside its premises.
Besides this, Mr. Bhartia said Jubilant and Duke would collaborate on two innovative biomarker studies to be conducted in Kolkata. The research would focus on molecule characteristics of several chronic diseases in India and also on the gene pool of Indian population
For information,with regards
rvk41...
Jubilant Organosys
Posted by :
dinesh_kguptaIs 265 right level for entering into the share...
Jubilant Organosys
Posted by : dinesh_kguptaWhat is the next target ?...
Hold on for another 2-3 days to see reasonable peak...
Jubilant Organosys
Posted by : rupesh711in
25 Oct 2009 22:03 Jubilant Organosys
Posted by : rupesh711in
Price when posted : BSE: Rs 237.30 ( 12.52 % ), NSE: Rs. 237.35 ( 12.33 % )View full discussion
Jubilant Organosys has made
Oct 23, 2009 Outside Bar (Bullish) Intermediate-Term Bullish at-237.30
Oct 23, 2009 Price Crosses Moving Average (21-day) Short-Term Bullish ai-237.30
Oct 23, 2009 Momentum Short-Term Bullish at-237.30
Oct 23, 2009 Continuation Wedge (Bullish) Intermediate-Term Bullish ai-237.30
intermediate to short term trgts - 266 - 275
long term trgts - 297 - 315
resist at - 243
support at - 236.50
stoploss at 213.55 ...
...
uc
Posted by : LEO THE LIONsee jubilant..........!...
